Educational Interventions for Patients With DCIS

Dana-Farber Cancer Institute

Status: Completed

Conditions: DCIS

Treatments: Device: Decision Board

Study type: Interventional

Funder types: Other

Identifiers

NCT00148655

02-331

Details and patient eligibility

About

The purpose of this study is to determine whether adding an educational intervention, in the form of a decision board, which outlines the risks and benefits of treatment options for DCIS, at the time of the first surgical consultation will improve decision making for women with DCIS.

Full description

• The decision board explains the risks and benefits of mastectomy, excision and radiation, excision, radiation, and tamoxifen, excision alone, and excision without radiation and tamoxifen for women with DCIS.
• Patients will receive a decision board to take home for review. Two fifteen-minute telephone interviews will be conducted, one approximately one week after enrollment and one 2 months after enrollment.
• In the phone interviews, patients will asked to complete a brief survey. This survey will ask abou DCIS in general, the patient's treatment decisions, their feelings, as well as their experience with the decision board.
• This study will take about 2 months.

Enrollment: 120 estimated patients

Sex: Female

Ages: 25+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Eligible patients will include women over the age of 25 with newly-diagnosed DCIS who are candidates for breast conserving therapy.
• Pathologic confirmation of DCIS without evidence of invasive breast cancer and mammograms showing a single suspicious focus without mammographic or clinical evidence of multicentricity.
• Patients that have not made a decision regarding management of DCIS
• Eligible for radiotherapy to breast
• Oral and written knowledge of English

Exclusion criteria

• Patients that have undergone mastectomy
• History of prior radiotherapy to the breast, scleroderma or systemic lupus erythematosus
• Clinically palpable disease in the axilla or contralateral breast cancer
• Co-morbidities that would render them ineligible for general anesthesia